Senvest Capital
VC Fund
Montreal, Canada
Senvest Capital is a VC fund in Montreal focused on Health Care and Medical Device. Headquartered in Montreal, Canada, Senvest Capital operates as a holding company with interests in investment management and direct investing in public securities and private investments. Senvest, publicly traded since 1971 and presently listed on the Toronto Stock Exchange, was originally founded as the exclusive Canadian licensee and distributorfor US-based Sensormatic Electronics, a pioneer in anti-theft-at-retail electronic security systems. Among other businesses acquired and operated by the company, Senvest Capital also spearheaded the development and operated one of Canada’s first cable pay-TV channels, First Choice, which it sold to a leading Canadian media company Astral Media.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 13%
Last updated:
For AI agents: llms.txt
Industries Senvest Capital invests in
Stages Senvest Capital invests in
Countries Senvest Capital invests in
Investment Focus
Industry
- Health Care 2 (25%)
- Medical Device 2 (25%)
- Audio 1 (13%)
- Music 1 (13%)
- Video 1 (13%)
Stage
- Seed 1 (13%)
- Pre-Seed 1 (13%)
- Series A 1 (13%)
- Series B 1 (13%)
- Series C 1 (13%)
Country
- United States 2 (25%)
- Canada 1 (13%)
- Israel 1 (13%)
- Sweden 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes. The company developing an end-to-end type 1 diabetes management system using a simple design, cloud connectivity, and human-centered automation. It optimizes the dosing and delivery of insulin through an integrated medical deviceecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care.Biofoot Biomedical ’s pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model. By employing data-driven intelligence across an integrated device ecosystem, they are transforming diabetes care with a fully comprehensive digital drug delivery platform experienced as a service. | $55.1M / Series C / Jan 13, 2020 | ||
| Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes. The company developing an end-to-end type 1 diabetes management system using a simple design, cloud connectivity, and human-centered automation. It optimizes the dosing and delivery of insulin through an integrated medical deviceecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care.Biofoot Biomedical ’s pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model. By employing data-driven intelligence across an integrated device ecosystem, they are transforming diabetes care with a fully comprehensive digital drug delivery platform experienced as a service. | $18M / Series B / Mar 21, 2018 | ||
| Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes. The company developing an end-to-end type 1 diabetes management system using a simple design, cloud connectivity, and human-centered automation. It optimizes the dosing and delivery of insulin through an integrated medical deviceecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care.Biofoot Biomedical ’s pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model. By employing data-driven intelligence across an integrated device ecosystem, they are transforming diabetes care with a fully comprehensive digital drug delivery platform experienced as a service. | $37M / Series B / Dec 18, 2017 | ||
| UNLIMITED is at the forefront in the design and creation of high-end Virtual Reality Experiences. VR is a revolutionary new medium - a mind-blowing hybrid between interactive media and immersive cinematic experiences. They offer branded and original VR content for immersive and interactive media, including films, TV series, games andadvertising. | $805K / Seed / Aug 30, 2017 | ||
| Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes. The company developing an end-to-end type 1 diabetes management system using a simple design, cloud connectivity, and human-centered automation. It optimizes the dosing and delivery of insulin through an integrated medical deviceecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care.Biofoot Biomedical ’s pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model. By employing data-driven intelligence across an integrated device ecosystem, they are transforming diabetes care with a fully comprehensive digital drug delivery platform experienced as a service. | Series A / Oct 05, 2016 | ||
| Spotify is a commercial music streaming service that provides restricted digital content from a range of record labels and artists. Users can browse through the interface by artist, album, genre, playlist, record label, and direct searches.It also enables individuals to create, share, and edit playlists with other users. If users wantrecommendations, they can integrate their system with Last.fm, an application that provides music recommendations based on listening history. The radio feature installed in Spotify creates random playlists for its users that are related to preferred artists.Spotify is available for mobile device platforms such as Android, Blackberry, Boxee, iOS, Linux, MeeGo, Squeezebox, Windows mobile, and more. | $526M / Series G / Jun 10, 2015 | ||
| Medical device company focused on innovative endoscopic procedures and devices. Medigus developed an entire endoscopic system for intraluminal treatment of GERD (Gastroesophageal Reflux Disease), one of the most common chronic diseases in the Western world. The endoscopic system for the treatment of GERD - the SRS - combines a miniaturized videocamera, a surgical stapler and ultrasonic sights for alignment in a single instrument. The SRS system and its unique flexible endoscope allows gastroenterologists and surgeons to perform endoluminally a true partial anterior fundoplication, thereby revolutionizing the treatment of GERD by eliminating the need for open or laparoscopic surgery - the current standard practice for treating severe GERD. Shifting the GERD treatment from surgery to an endoluminal procedure, without opening the abdominal cavity, is a REVOLUTION. In addition, Medigus designs and manufactures endoscopy systems for partner companies based on its proprietary technologies, which include all necessary elements for performing a wide range of endoscopic procedures such as the world’s smallest video cameras, respective video processors and endoscopy suits, and various types of rigid, semi-flexible and flexible disposable video endoscopes. | $11.1M / Post-IPO Equity / Jun 29, 2014 | ||
| Breakthrough is to transform the sales process by harnessing the power of AI to deliver high-quality, personalized sales pitches at scale.They believe that the heart of any successful sales strategy lies in the message itself, and we are committed to helping businesses craft tailored, relevant pitches that resonate with prospects. | $600K / Pre-Seed |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Senvest Capital invest in?
Senvest Capital invests primarily in Health Care, Medical Device and Audio startups, most often at Seed and Pre-Seed stage. Most of the 8 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Senvest Capital last invest?
The most recent investment recorded for Senvest Capital closed in Jan 2020. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
